These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18411995)

  • 1. Chronic kidney disease anaemia. 2: Overview of guidance.
    Roche A; Jenkins K; Johnson C
    Nurs Times; 2008 Mar 4-10; 104(9):28-9. PubMed ID: 18411995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic kidney disease anaemia 1: diagnosis and screening.
    Roche A; Jenkins K; Johnson C
    Nurs Times; 2008 Feb 26-Mar 3; 104(8):26-7. PubMed ID: 18372672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The KDOQI clinical practice guidelines and clinical practice recommendations for treating anemia in patients with chronic kidney disease: implications for nurses.
    McCarley P
    Nephrol Nurs J; 2006; 33(4):423-6, 445; quiz 427-8. PubMed ID: 17002000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [IV iron or oral iron in anaemic patient with CKD].
    Frimat L; Thilly N; Boini S
    Nephrol Ther; 2006 Nov; 2 Suppl 5():S347-9. PubMed ID: 17373282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CE: Continuing Education article. Patient management in CKD stages 1 TO 3.
    Murphy F; Jenkins K; Chamney M; McCann M; Sedgewick J
    J Ren Care; 2008 Sep; 34(3):127-35. PubMed ID: 18786079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A qualitative analysis of patient-reported symptoms of anemia.
    Lasch KF; Evans CJ; Schatell D
    Nephrol Nurs J; 2009; 36(6):621-4, 631-2; quiz 633. PubMed ID: 20050515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of anemia in patients with chronic kidney disease.
    Wish JB
    Postgrad Med; 2004 Nov; 116(5 Suppl Anemia):23-9. PubMed ID: 19667681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The First European Renal Association-European Dialysis and Transplant Association CKD Anaemia Physician Behaviours Survey: key findings.
    Cannata-Andía JB; Locatelli F; Zoccali C
    J Nephrol; 2008; 21(2):190-6. PubMed ID: 18446713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaemia and mineral bone disorder in chronic kidney disease: a review of the current literature and implications for clinical nursing practice.
    Limrick C; McNichols-Thomas C
    J Ren Care; 2009 Mar; 35 Suppl 1():94-100. PubMed ID: 19222739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cardio-renal anemia syndrome.
    Iaina A; Silverberg DS; Wexler D; Iaina Nomy L
    Med Pregl; 2007; 60 Suppl 2():145-50. PubMed ID: 18928182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do anaemia co-ordinators have to be nurses?
    Sanders D; Hibbert D; Ackrill P; Clinkard S; Cooke J; Cottrell N
    EDTNA ERCA J; 1999; 25(2):39-41. PubMed ID: 10531882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anemia and cardiovascular risk in the patient with kidney disease.
    Fishbane S
    Heart Fail Clin; 2008 Oct; 4(4):401-10. PubMed ID: 18760752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving efficiency and value in health care. Intravenous iron management for anaemia associated with chronic kidney disease: linking treatment to an outpatient clinic, optimizing service provision and patient choice.
    Bhandari S; Naudeer S
    J Eval Clin Pract; 2008 Dec; 14(6):996-1001. PubMed ID: 18785894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous iron in chronic kidney disease: haemoglobin change shortly after treatment of patients neither on dialysis nor on erythropoietin.
    Tagboto S; Cropper L; Mostafa S; Turner J; Bailey G; Pugh-Clarke K
    J Ren Care; 2008 Sep; 34(3):112-5. PubMed ID: 18786076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anemia of heart failure.
    Silverberg DS; Wexler D; Palazzuoli A; Iaina A; Schwartz D
    Acta Haematol; 2009; 122(2-3):109-19. PubMed ID: 19907148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs of managing anemia with erythropoiesis-stimulating agents during hemodialysis: a time and motion study.
    Schiller B; Doss S; DE Cock E; Del Aguila MA; Nissenson AR
    Hemodial Int; 2008 Oct; 12(4):441-9. PubMed ID: 19090867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of neocytolysis for optimal management of anaemia in chronic kidney disease.
    Alfrey CP; Fishbane S
    Nephron Clin Pract; 2007; 106(4):c149-56. PubMed ID: 17596723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CE: Continuing Education article. Patient management in chronic kidney disease stages 4 to 5.
    Murphy F; Jenkins K; McCann M; Sedgewick J
    J Ren Care; 2008 Dec; 34(4):191-8. PubMed ID: 19090897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of anaemia on mortality, cardiovascular hospitalizations and end-stage renal disease among patients with chronic kidney disease.
    Thorp ML; Johnson ES; Yang X; Petrik AF; Platt R; Smith DH
    Nephrology (Carlton); 2009 Apr; 14(2):240-6. PubMed ID: 19207866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anemia: the point of convergence or divergence for kidney disease and heart failure?
    Kazory A; Ross EA
    J Am Coll Cardiol; 2009 Feb; 53(8):639-47. PubMed ID: 19232895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.